919 resultados para number of days on test
Resumo:
Mode of access: Internet.
Resumo:
Includes index.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Goldsmiths'-Kress no. 27139.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
With: Mathematical tables / John Gummere. Stereotyped ed., carefully rev. and corrected. Philadelphia : Kimber & Sharpless, 1843.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Reply to Louis Hue Girardin's "Pulaski vindicated from an unsupported charge inconsiderately or malignantly introduced in Judge Johnson's Sketches of the life and correspondence of Major Gen. Nathaniel Greene."
Resumo:
"Answer to the strictures of Mr. T. Falconer": and "Mr. Falconer's reply to Mr. Greenhow's answer, with Mr. Greenhow's rejoinder".
Resumo:
Mode of access: Internet.
Resumo:
Background. Prostate-specific antigen (PSA) testing for prostate cancer is controversial. Demand for PSA testing is likely to rise in the UK, Australia and other western countries. Primary care needs to develop appropriate strategies to respond to this demand. Objectives. Our aim was to compare the effectiveness of educational outreach visits (EOVs) and mailout strategies targeting PSA testing in Australian primary care. Methods. A randomized controlled trial was conducted in general practices in southern Adelaide. The main outcome measures at baseline, 6 months and 12 months post-intervention were PSA testing rates and GP knowledge in key areas relating to prostate cancer and PSA testing. Results. The interventions were able to demonstrate a change in clinical practice. In the 6 months post-intervention, median PSA testing rate in the EOV group was significantly lower than in the postal group, which in turn was significantly lower than the control group (P < 0.001). Statistically significant differences were not, however, maintained in the 6-12 month post-intervention period. The EOV group, at 6 months follow-up, had a significantly greater proportion of 'correct' responses than the control group to questions about prostate cancer treatment effectiveness (P = 0.004) and endorsement of PSA screening by professional bodies (P = 0.041). Conclusions. Primary care has a central role in PSA testing for prostate cancer. Clinical practice in this area is receptive to evidence-based interventions.